Chronic obstructive pulmonary disease and COVID-19: interrelationships

D Singh, AG Mathioudakis… - Current opinion in …, 2022 - journals.lww.com
Chronic obstructive pulmonary disease and COVID-19: interrel... : Current Opinion in
Pulmonary Medicine Chronic obstructive pulmonary disease and COVID-19 …

[HTML][HTML] Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

S Momtazmanesh, SS Moghaddam, SH Ghamari… - …, 2023 - thelancet.com
Background Updated data on chronic respiratory diseases (CRDs) are vital in their
prevention, control, and treatment in the path to achieving the third UN Sustainable …

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive …

LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville… - The Lancet, 2021 - thelancet.com
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …

PulDi-COVID: Chronic obstructive pulmonary (lung) diseases with COVID-19 classification using ensemble deep convolutional neural network from chest X-ray …

YH Bhosale, KS Patnaik - Biomedical Signal Processing and Control, 2023 - Elsevier
Abstract Background and Objective In the current COVID-19 outbreak, efficient testing of
COVID-19 individuals has proven vital to limiting and arresting the disease's accelerated …

Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta …

S Chenchula, K Vidyasagar, S Pathan, S Sharma… - Scientific reports, 2023 - nature.com
A COVID-19 patient often presents with multiple comorbidities and is associated with
adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in …

Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality

J Ren, W Pang, Y Luo, D Cheng, K Qiu, Y Rao… - The Journal of Allergy …, 2022 - Elsevier
Background It remains unclear if patients with allergic rhinitis (AR) and/or asthma are
susceptible to corona virus disease 2019 (COVID-19) infection, severity, and mortality …

Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

U Radzikowska, A Eljaszewicz, G Tan… - Nature …, 2023 - nature.com
Rhinoviruses and allergens, such as house dust mite are major agents responsible for
asthma exacerbations. The influence of pre-existing airway inflammation on the infection …

Short and long-term impact of COVID-19 infection on previous respiratory diseases

E Chiner-Vives, R Cordovilla-Perez… - Archivos de …, 2022 - Elsevier
Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

IoT deployable lightweight deep learning application for COVID-19 detection with lung diseases using RaspberryPi

YH Bhosale, KS Patnaik - 2022 International conference on IoT …, 2022 - ieeexplore.ieee.org
Proper assessment of COVID-19 patients has become critical to mitigating and halting the
disease's rapid expansion during the present COVID-19 epidemic across the nations. Due to …

Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview

A Gupta, H Marzook, F Ahmad - Clinical and experimental medicine, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …